Leon J. Thal, MD
Affiliations: | Neuroscience | University of California, San Diego, La Jolla, CA |
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=27Website:
http://ucsdnews.ucsd.edu/newsrel/health/thal07.aspGoogle:
"Leon Thal"Bio:
http://www.alzforum.org/spotlight/Thaltribute.asp
http://www.nia.nih.gov/NewsAndEvents/20070209Thal.htm
http://healthspan.ucsd.edu/2010/07/Pages/som-thal-award.aspx
Mean distance: 17.84 (cluster 32)
Cross-listing: Alzheimer's Tree
Children
Sign in to add trainee| Jody Corey-Bloom | post-doc | UCSD | |
| Douglas R. Galasko | post-doc | UCSD | |
| Michael S. Rafii | post-doc | 2006-2008 | UCSD |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tariot PN, Schneider LS, Cummings J, et al. (2011) Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Archives of General Psychiatry. 68: 853-61 |
| Rapp SR, Legault C, Henderson VW, et al. (2010) Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study. Alzheimer Disease and Associated Disorders. 24: 248-55 |
| Apostolova LG, Thompson PM, Green AE, et al. (2010) 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Human Brain Mapping. 31: 786-97 |
| Vellas B, Black R, Thal LJ, et al. (2009) Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Current Alzheimer Research. 6: 144-51 |
| Hamilton JM, Salmon DP, Galasko D, et al. (2008) Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 22: 729-37 |
| Aisen PS, Schneider LS, Sano M, et al. (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama. 300: 1774-83 |
| van Straaten EC, Harvey D, Scheltens P, et al. (2008) Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. Journal of Neurology. 255: 1302-8 |
| Fleisher AS, Raman R, Siemers ER, et al. (2008) Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology. 65: 1031-8 |
| Fine EM, Delis DC, Wetter SR, et al. (2008) Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 366-74 |
| Aisen PS, Thal LJ, Ferris SH, et al. (2008) Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial. Current Alzheimer Research. 5: 73-82 |